GLP-1 RA-anti TfR antibody fusion protein (Novo Nordisk)

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameGLP-1 RA-anti TfR antibody fusion protein (Novo Nordisk)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Transferrin receptorsGlucagon-like peptide 1 receptor agonists
TargetsTransferrin receptorsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A